| MRMD Stock | | | USD 0.15 0.01 6.25% |
Insider
Susan CPA is Chief Officer of Marimed
| Age | 55 |
| Phone | 617 795 5140 |
| Web | https://www.marimedinc.com |
Marimed Management Efficiency
The company has return on total asset
(ROA) of
0.0921 % which means that it generated a profit of $0.0921 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity
(ROE) of
0.0303 %, meaning that it created $0.0303 on every $100 dollars invested by stockholders. Marimed's management efficiency ratios could be used to measure how well Marimed manages its routine affairs as well as how well it operates its assets and liabilities.
Marimed currently holds 448.34
K in liabilities with Debt to Equity
(D/E) ratio of 0.35, which is about average as compared to similar companies. Marimed has a current ratio of 1.3, suggesting that it
may not be capable to disburse its financial obligations when due. Debt can assist Marimed until it has trouble settling it off, either with new capital or with free cash flow. So, Marimed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Marimed sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Marimed to invest in growth at high rates of return. When we think about Marimed's use of debt, we should always consider it together with cash and equity.
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts. Marimed operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 260 people. Marimed [MRMD] is traded as part of a regulated electronic over-the-counter service offered by the NASD.
Management Performance
Marimed Leadership Team
Elected by the shareholders, the Marimed's board of directors comprises two types of representatives: Marimed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Marimed. The board's role is to monitor Marimed's management team and ensure that shareholders' interests are well served. Marimed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Marimed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Timothy Shaw, Chief Officer | |
| Steve West, VP Relations | |
| Howard Schacter, Chief Officer | |
| Sara Gullickson, VP Marketing | |
| Susan CPA, Chief Officer | |
| Jon Levine, President, CoFounder | |
| Charles Finnie, Chief Officer | |
| Ryan Crandall, VP Officer | |
| Robert Fireman, Chairman CoFounder | |
| Jonathan Rider, Chief Officer | |
Marimed Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Marimed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in Marimed OTC Stock
Marimed financial ratios help investors to determine whether Marimed OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Marimed with respect to the benefits of owning Marimed security.